SAFETY AND EFFICACY OF RECOMBINATE IN PREVIOUSLY UNTREATED HEMOPHILIA A PATIENTS

被引：0
|
作者：
BRAY, G
GORDON, EM
LIUMARUYA, S
COURTER, S
GOMPERTS, E
机构：
[1] CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010
[2] CHILDRENS HOSP,LOS ANGELES,CA 90027
[3] BAXTER HYLAND DIV,GLENDALE,CA
来源：
TRANSFUSION | 1992年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of recombinant factor VIII for the treatment of previously treated patients with hemophilia A in China
    Yang, R.
    Zhao, Y.
    Sun, J.
    Wu, J.
    Wang, X.
    Yu, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 507 - 507
  • [32] Efficacy and safety of ReFacto AF for surgical hemostasis in previously treated patients with severe hemophilia A
    Windyga, Jerzy
    Rusen, Luminita
    El-Hashimy, Mona
    Roth, David A.
    Arkin, Steven
    BLOOD, 2007, 110 (11) : 58B - 58B
  • [33] Eight years of pharmacovigilance evaluation with ReFacto® -: safety and efficacy in previously untreated haemophilia A patients
    Pollmann, H.
    HAEMOPHILIA, 2008, 14 : 52 - 52
  • [34] Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia
    Rossi, JF
    Van Hoof, A
    De Boeck, K
    Johnson, SA
    Bron, D
    Foussard, C
    Lister, TA
    Berthou, C
    Kramer, MHH
    Littlewood, TJ
    Marcus, RE
    Deconinck, E
    Montillo, M
    Guibon, O
    Tollerfield, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1260 - 1267
  • [35] Modified Primary Prophylaxis in Previously Untreated Patients With Severe Hemophilia A in Iran
    Karimi, Mehran
    Eshghi, Peyman
    Safarpour, Mohammad M.
    Haghpanah, Sezaneh
    Meshksar, Aidin
    Zahedi, Zohreh
    Habibpanah, Behnaz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 188 - 191
  • [36] Incidence of factor VIII inhibitor in Korean previously untreated hemophilia A patients
    Yoo, Ki Young
    Park, Young Shil
    Kim, Ji Yoon
    HAEMOPHILIA, 2018, 24 : 28 - 28
  • [37] Considerations for shared decision management in previously untreated patients with hemophilia A or B
    Astermark, Jan
    Blatny, Jan
    Koenigs, Christoph
    Hermans, Cedric
    Jimenez-Yuste, Victor
    Hart, Daniel P.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [38] Modified primary prophylaxis in previously untreated patients with severe hemophilia A in Iran
    Karimi, Mehran
    Eshghi, Peyman
    Meshksar, Aidin
    Safarpour, Mohammad Mostafa
    Haghpanah, Sezaneh
    Zahedi, Zohreh
    Habibpanah, Behnaz
    HAEMOPHILIA, 2016, 22 : 73 - 73
  • [39] ETHICAL DECISION MAKING FRAMEWORK IN PREVIOUSLY UNTREATED SEVERE HEMOPHILIA A PATIENTS
    Lanzel, Ashley Foster
    Soucie, J. Michael
    Ortmann, Leonard
    Barrett, Drue
    Sidonio, Robert, Jr.
    Meeks, Shannon
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [40] How I approach: Previously untreated patients with severe congenital hemophilia A
    Thornburg, Courtney D.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
12345